What's new

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 20, Status: Authorised

May 23, 2025 - 08:15
 0
Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory s...

Next Article

Allies review progress with NATO cyber defence pledge, identify next steps to in...

Related Posts

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

CTIS newsflash - 16 May 2025

May 19, 2025  0

Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Date of authorisation: 28/09/2009, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0